30
Views
45
CrossRef citations to date
0
Altmetric
Original Article

Doxazosin Treatment in Patients with Prostatic Obstruction

A Double-Blind Placebo-Controlled Study

, , , , , , , , & show all
Pages 39-44 | Received 07 Sep 1991, Accepted 27 Mar 1992, Published online: 15 Feb 2010

REFERENCES

  • Andersson K-E, Sjögren C. Aspects on the physiology and pharmacology of the bladder and urethra. Prog Neurobiol 1982; 19: 71–89.
  • Birch NC, Hurst G, Doyle PT. Serial residual volumes in men with prostatic hypertrophy. Br J Urol 1988; 62: 571–575.
  • Bruskewitz RC, Christensen MM. Critical evaluation of transurethral resection and incision of the prostate. Prostate 1990; Suppl 3: 27–38.
  • Bruskewitz RC, Iversen P, Madsen PO. Value of postvoid residual urine determination in evaluation of prostatism. Urology 1982; 20: 602–604.
  • Caine M. The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy. J Urol 1986; 136: 1–4.
  • Caine M. Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia. Urol Clin N Am 1991; 17: 641–649.
  • Caine M, Raz S, Zeigler M. Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br J Urol 1975; 47: 193–202.
  • Chapple CR, Aubry ML, James S et al. Characterization of human prostatic adrenoceptors using pharmacologic receptor binding and localization. Br J Urol 1989; 63: 487–496.
  • Chapple CR, Christmas TJ, Milroy EJG. A twelve-week placebo-controlled study of prazosin in the treatment of prostatic obstruction. Urol Int 1990; 45 (Suppl): 47–55.
  • Furuya S, Kumamoto Y, Yokoyama E et al. Alpha-adrenergic activity and urethral pressure in prostatic zone in benign prostatic hypertrophy. J Urol 1982; 128: 836–839.
  • Hedlund H, Andersson K-E, Ek A. Effects of prazosin in patients with benign prostatic obstruction. J Urol 1983; 130: 275–278.
  • Hedlund H, Andersson K-E, Larsson B. Alpha-adrenoceptors and muscarinic receptors in the isolated human prostate. J Urol 1985; 134: 1291–1298.
  • Herbison AE, Fraundorfer MR, Walton JK. Association between symptomatology and uroflowmetry in benign prostatic hypertrophy. Br J Urol 1988; 62: 427–430.
  • Iacovou JW, Dunn M. Indoramin—an effective new drug in the management of bladder outflow obstruction. Br J Urol 1987; 60: 526–528.
  • Kirby RS, Coppinger SWC, Corcoran MO et al. Prazosin in the treatment of prostatic obstruction. A placebo-controlled study. Br J Urol 1987; 60: 136–142.
  • Le Duc A, Cariou G, Baron C et al. A multicenter, double-blind, placebo-controlled trial of the efficacy of prazosin in the treatment of dysuria associated with benign prostatic hypertrophy. Urol Int 1990; 45 (Suppl): 56–62.
  • Lepor H, Shapiro E. Characterization of alpha1 adrenergic receptors in human benign prostatic hyperplasia. J Urol 1984; 132: 1226–1229.
  • Martorana G, Giberti C, Damonte P et al. The effect of prazosin in benign prostatic hypertrophy, a placebo controlled double-blind study. IRCS Med Sci 1984; 12: 11–12.
  • Neal DE, Ramsden PD, Sharples L et al. Outcome of elective prostatectomy. Br Med J 1989; 299: 762–767.
  • Perlberg S, Caine M. Adrenergic response of bladder muscle in prostatic obstruction. Its relation to detrusor instability. Urology 1982; 20: 524–527.
  • Rohner TJ, Hannigan JD, Sanford EJ. Altered in vitro adrenergic responses of dog detrusor muscle after chronic bladder outlet obstruction. Urology 1978; 11: 357–361.
  • Sertcelik MN, Unal S, Ozgur S et al. Prazosin, a selective alpha1 receptor blocker, in the treatment of benign prostatic hypertrophy. Curr Ther Res 1990; 48: 1066–1074.
  • Taylor SH. Pharmacotherapeutic stature of doxazosin and its role in coronary risk reduction. Am Heart J 1988; 116: 1735–1747.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.